• Thermal Shift Assays for Bacterial Sensor Ligands

  2026-09-15

  Monteagudo-Cascales and colleagues review how thermal shift assays can reveal ligands for bacterial receptors, solute-binding proteins, and transcriptional regulators when their signals are unknown. The paper’s main practical contribution is a reliability framework that combines soluble ligand-binding domains, pH optimization, careful hit interpretation, and orthogonal validation such as isothermal titration calorimetry.

• BMS-345541 Hydrochloride: IKK Signaling and Cell Death

  2026-09-14

  BMS-345541 hydrochloride is an allosteric IKK inhibitor that connects NF-κB pathway control with context-dependent apoptosis and necroptosis. This guide uses RIPK1 phosphoregulation research to develop a more discriminating framework for inflammation research, T-ALL assays, and mechanistic experimental design.

• PPT for ERα Signaling: Practical Assays

  2026-09-14

  PPT (Propyl Pyrazole Triol) gives researchers a pharmacological way to isolate ERα activity from ERβ signaling in cell, gene-expression, and uterotrophic assay workflows. This guide translates its selectivity into practical experiments for validating ERα-mediated gene expression and probing FOXM1–ERα biology in female lung adenocarcinoma.

• Tetraethylammonium Chloride: From Pore to Proof

  2026-09-13

  Tetraethylammonium chloride (TEAC) is more than a conventional potassium-channel blocker: its access to internal and external pore sites makes it a practical probe for linking ion conduction to phenotype. This thought-leadership guide translates classic channel biology into a rigorous workflow for vascular, endocrine, neuronal, and translational research while clarifying where TEAC provides evidence—and where it does not.

• Trypsin for Protease-Aware Cell and Cartilage Research

  2026-09-12

  Trypsin is more than a routine dissociation reagent: its cleavage specificity can shape cell-state measurements, protein assays, and viral membrane-fusion experiments. This article connects serine protease handling with the SMAD3–miRNA-140–ADAMTS-5 osteoarthritis pathway while defining practical boundaries between sample preparation and biological interpretation.

• Macrophage EV miR-660 Drives Breast Cancer Metastasis

  2026-09-11

  The reference study identifies a macrophage-to-tumor communication route in which extracellular vesicles deliver miR-660 to breast cancer cells, suppressing KLHL21 and activating the IKKβ/NF-κB p65 axis. Its combined tissue, cell, extracellular-vesicle, and mouse experiments connect tumor-microenvironment signaling with metastatic behavior while also defining important limits for translating the pathway into therapeutic or autophagy-focused research.

• Rimonabant and the Next CB1 Research Playbook

  2026-09-11

  Rimonabant (SR141716) is more than a selective CB1 probe: it is a strategic tool for separating receptor-driven effects from behavioral context. This article examines how sex-aware withdrawal models, appetite research, and disciplined protocol design can improve translational decisions around CB1 pharmacology.

• AAPH Oxidative Stress Assays: Uses and Workflow

  2026-09-10

  AAPH provides a water-soluble, sustained source of peroxyl-radical stress for erythrocyte hemolysis, lipid peroxidation, antioxidant screening, and protein-oxidation workflows. This practical guide connects assay setup and troubleshooting with new PRDX6–GPX4 findings relevant to ferroptosis research.

• DAPI Nuclear Stain Solution: Workflow Guide

  2026-09-10

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution K2402 is a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint cell viability assessment. Its weak cell permeability makes it more appropriate for fixed or membrane-compromised samples than for routine imaging of intact live cells, and DAPI signal alone should not be treated as a specific apoptosis diagnosis.

• Vancomycin hydrochloride in Translational Assays

  2026-09-09

  Use Vancomycin hydrochloride as a defined Gram-positive challenge, contamination-control probe, and resistance benchmark—not as an indiscriminate substitute for sterility testing. This guide connects practical susceptibility workflows with the reference study’s engineered-esophagus model while clearly separating validated findings from proposed assay adaptations.

• VERTIS CV: Ertugliflozin Cardiovascular Outcomes

  2026-09-09

  The VERTIS CV trial established that ertugliflozin was noninferior to placebo for major adverse cardiovascular events in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Its rigorous event-driven design also identified clinically relevant trends in heart-failure and renal outcomes, while showing why noninferiority evidence should not be interpreted as proof of cardiovascular superiority.

• Cytochalasin D: From Actin to Translational Insight

  2026-09-08

  Cytochalasin D is more than a cytoskeletal inhibitor. By connecting actin-dependent phenotypes with cell-cycle control, tumor biology, antiviral research, and nanoparticle uptake, translational teams can use this mechanistic probe to design more discriminating experiments and avoid overinterpreting broad cellular responses.

• LMO2–LDB1 Mechanism in AML

  2026-09-08

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia cell proliferation and survival. By combining genetic perturbation, protein-interaction analysis, functional assays, and transcriptomic and chromatin profiling, the work connects LDB1 activity with apoptosis-related gene regulation and shows that LMO2 can partially compensate for LDB1 loss.

• Trim71–Ago2 Control of let-7 in Stem Cells

  2026-09-07

  Liu et al. show that the RNA-binding protein Trim71 maintains mouse embryonic stem-cell pluripotency by repressing Ago2 mRNA translation, thereby limiting maturation of let-7 microRNAs. The study provides mechanistic support for a Trim71–let-7 bistable switch and offers an experimental framework for separating transcript-level, translational, and mature microRNA effects during stem-cell differentiation.

• CNQX and the Logic of Circuit-Level Translation

  2026-09-07

  CNQX is more than a standard AMPA/kainate antagonist: used strategically, it can distinguish receptor-class contributions within complex neurocardiovascular circuits. Evidence from chemerin signaling in the caudal nucleus tractus solitarius illustrates how a negative CNQX result can sharpen, rather than weaken, mechanistic interpretation.

716 records 6/48 page Previous Next First page 上5页 678910 下5页 Last page